Newstral
Article
bizjournals.com on 2017-03-09 16:47
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Related news
- DMartin Shkreli’s former company files for bankruptcyDaily News
- MBernie Sanders doesn't need Martin Shkreli’s stinkin’ biotech moneymarketwatch.com
- Martin Shkreli’s other pharma company is dramatically collapsingArs Technica
- SMartin Shkreli’s Daraprim Scandalseren.bangor.ac.uk
- NJudge amused by having two ‘Martin Shkreli’s in federal courtnypost.com
- Martin Shkreli’s Former Company Ordered to Pay $40 Million in Settlement Over Price-Gouging Casewsj.com
- Polish biotech research services company sets U.S. headquarters in Cambridgebizjournals.com
- TMartin Shkreli’s most dangerous gamethedmonline.com
- Martin Shkreli’s Legacy Upends a Creative Financierwsj.com
- Court upholds ‘Pharma Bro’ Martin Shkreli’s convictionreviewtimes.com
- WPharma CEO Martin Shkreli’s Twitter account hackedwhitecourtpress.com
- ‘Greedy’ CEO Martin Shkreli’s latest purchasenews.com.au
- Martin Shkreli’s Wu-Tang Album Could Be Seized by GovernmentThe New York Times
- N‘Pharma bro’ Martin Shkreli’s fraud trial kicks offnypost.com
- The feds have Martin Shkreli’s Wu-Tang albumThe Verge
- No one wants ‘pharma bro’ Martin Shkreli’s help with coronavirusdazeddigital.com
- HCourt Upholds ‘Pharma Bro’ Martin Shkreli’s Convictionhamodia.com
- MMartin Shkreli’s KaloBios files for bankruptcymarketwatch.com
- NJudge won’t toss Martin Shkreli’s conspiracy and fraud convictionnypost.com